Get in the KNOW
on LA Startups & Tech
XCOVID Labs Tasked With Testing Mandate
Keerthi Vedantam is a bioscience reporter at dot.LA. She cut her teeth covering everything from cloud computing to 5G in San Francisco and Seattle. Before she covered tech, Keerthi reported on tribal lands and congressional policy in Washington, D.C. Connect with her on Twitter, Clubhouse (@keerthivedantam) or Signal at 408-470-0776.
Los Angeles health care workers and school faculty (who are unable to get vaccinated) are now mandated by the state to get tested regularly. In the city and county, municipal employees from bus drivers to police officers are also required to be tested regularly if they do not get vaccinated.
Meanwhile, commercial labs, medical labs and public health labs are tasked with making sure the tests get processed and rapidly turned around. PCR tests, the most accurate kind of COVID-19 test that looks for viral RNA, are only useful if results are given within two days of taking the sample. Any longer than that, and California residents who unknowingly have the virus risk spreading it to more people.
"If it's longer than [two days] then the test results become less useful from a public health perspective," said Jeff Klausner, an infectious disease expert and member of the state's coronavirus testing task force. "The idea initially was to use contact tracing to find out who was positive as fast as possible to disrupt the chain of transmission. But given the huge number of cases that wasn't useful."
Of course, even two days of turnaround time isn't a foolproof way to stop the coronavirus from spreading. Someone could give a sample on one day, contract the virus later that day, and not know until a week later when they take another PCR test. But the state sees it as a more efficient method than contact tracing.
The two-day turnaround time has forced labs to stay open 24/7, with lab workers taking shifts under a rotating cast of managers. Some companies, like SummerBio, have automated the testing process to turn around thousands of results in the span of two days. It's a leap from the start of the pandemic, when companies struggling with inefficient supply were struggling to process tests any shorter than a week.
Labs processed nearly 1.6 million COVID-19 tests for Californians between Aug. 8 and Aug. 14, a big jump from the peak of the pandemic last winter, when labs were processing around half a million tests a day. That number will need to grow exponentially, as mandates send millions of California students and workers to testing sites as the delta variant surges. Klausner said the state has the capacity to process about 4 to 5 million tests a week.
"Right now we're in a way different place than we were [in] March 2020 when it made sense to declare a state of emergency to get prepared," Klausner, a member of the California coronavirus testing task force, said. "Now it doesn't make sense to continue the state of emergency. And we have a lot of laboratory capacity and there's a lot of underutilization."
That's not to say the state may run into problems down the line. Supply shortages, malfunctions in labs that are processing the bulk of tests could net false-positive COVID-19 results, or bring us back to the beginning of the pandemic, when test results took weeks to return and public officials scrambled to create the infrastructure to support mass testing amid supply shortages.
This could also further fuel the spread of the hyper-contagious delta variant.
The California Department of Public Health said it could not provide an estimate on how many workers in California were bound by a testing mandate.
"The number of people mandated to get tested on a regular basis is determined by those who eventually become vaccinated and those who remain unvaccinated. Therefore, it is a fluid number," a department representative said by email.
Here are the top ten labs in the state and how quickly they turned tests for the week of Aug. 8:
SummerBio
- TESTS PERFORMED: 267,405
- RESULTS WITHIN TWO DAYS: 99%
- RESULTS AFTER 2 DAYS: 1%
SummerBio, which has contracted with the Los Angeles School District, to test students and employees was responsible for approximately 8% of all COVID-19 testing in the first week of August. The company, based in Menlo Park, CA, was founded in 2020 and quickly raised $7.3 million to test for the coronavirus. While LAUSD is its biggest customer, the company has also partnered with UCLA, San Diego Unified School District, and a slew of large companies.
Fulgent Genetics
- TESTS PERFORMED: 146,836
- RESULTS WITHIN TWO DAYS: 99%
- RESULTS AFTER 2 DAYS: 1%
The ten-year-old diagnostics company Fulgent Genetics has long been involved in genetic testing to screen for hereditary conditions and cancers. It has leveraged its partnerships with hospitals, large companies and cities to test for COVID.
Valencia Branch Lab
- TESTS PERFORMED: 118,184
- RESULTS WITHIN TWO DAYS: 95%
- RESULTS AFTER 2 DAYS: 5%
Valencia Branch Lab is a public health laboratory north of Los Angeles that has partnered with Color, a startup creating testing kits for hereditary health problems that pivoted to COVID testing during the pandemic. In February, the California Department of Public Health announced multiple samples at the lab were either incorrectly processed or unable to be processed due to lab errors, but the company in charge of the lab said those errors have since been resolved.
Kaiser SoCal
- TESTS PERFORMED: 87,523
- RESULTS WITHIN TWO DAYS: 100%
- RESULTS AFTER 2 DAYS: 0%
Kaiser SoCal, which comprises 15 hospitals across Southern California, has taken on the lion's share of COVID-19 testing across all medical institutions in the state. The group has two labs that can process 280,000 tests a week.
Quest
- TESTS: 77,232
- RESULTS WITHIN TWO DAYS: 89%
- RESULTS AFTER 2 DAYS: 11%
Quest Diagnostics, another senior diagnostics company that has been doing bloodwork long before the pandemic, quickly added COVID-19 testing to its slew of deliverables. The company's partnership with grocery stores like Safeway and Vons have allowed it to expand their reach.
- Here's How Curative, Inc, Plans to Roll Out Coronavirus Testing to ... ›
- Lab Launch Will Open a New Facility in LA's Atwater Village - dot.LA ›
- The COVID-19 Crisis is Creating a New Biotech Culture in L.A. - dot.LA ›
- Fulgent Genetics: 3 Things to Know About the Medtech Co. - dot.LA ›
Keerthi Vedantam is a bioscience reporter at dot.LA. She cut her teeth covering everything from cloud computing to 5G in San Francisco and Seattle. Before she covered tech, Keerthi reported on tribal lands and congressional policy in Washington, D.C. Connect with her on Twitter, Clubhouse (@keerthivedantam) or Signal at 408-470-0776.
Subscribe to our newsletter to catch every headline.
California Debates Data Privacy as SCOTUS Allows Abortion Bans
Keerthi Vedantam is a bioscience reporter at dot.LA. She cut her teeth covering everything from cloud computing to 5G in San Francisco and Seattle. Before she covered tech, Keerthi reported on tribal lands and congressional policy in Washington, D.C. Connect with her on Twitter, Clubhouse (@keerthivedantam) or Signal at 408-470-0776.
The United States Supreme Court called a Mississippi law banning abortion after 15 weeks constitutional on Friday, overturning the country’s founding abortion rights decision Roe v. Wade. The Supreme Court also upheld that there cannot be any restriction on how far into a pregnancy abortion can be banned.
When Politico first broke the news months before SCOTUS’s final ruling, a slew of bills entered Congress to protect data privacy and prevent the sale of data, which can be triangulated to see if a person has had an abortion or if they are seeking an abortion and have historically been used by antiabortion individuals who would collect this information during their free time.
Democratic lawmakers led by Congresswoman Anna Eshoo called on Google to stop collecting location data. The chair of the Federal Trade Commission has long voiced plans for the agency to prevent data collection. A week after the news, California Assembly passed A.B. 2091, a law that would prevent insurance companies and medical providers from sharing information in abortion-related cases (the state Senate is scheduled to deliberate on it in five days).
These scattered bills attempt to do what health privacy laws do not. The Health Insurance Portability and Accountability Act, or HIPAA, was established in 1996 when the Internet was still young and most people carried flip phones. The act declared health institutions were not allowed to share or disclose patients’ health information. Google, Apple and a slew of fertility and health apps are not covered under HIPAA, and fertility app data can be subpoenaed by law enforcement.
California’s Confidentiality of Medical Information Act (or CMIA), goes further than HIPAA by encompassing apps that store medical information under the broader umbrella of health institutions that include insurance companies and medical providers. And several how-tos on protecting data privacy during Roe v. Wade have been published in the hours of the announcement.
But reproductive rights organizations say data privacy alone cannot fix the problem. According to reproductive health policy think tank Guttmacher Institute, the closest state with abortion access to 1.3 million out-of-state women of reproductive age is California. One report from the UCLA Center on Reproductive Health, Law and Policy estimates as many as 9,400 people will travel to Los Angeles County every year to get abortions, and that number will grow as more states criminalize abortions.
Keerthi Vedantam is a bioscience reporter at dot.LA. She cut her teeth covering everything from cloud computing to 5G in San Francisco and Seattle. Before she covered tech, Keerthi reported on tribal lands and congressional policy in Washington, D.C. Connect with her on Twitter, Clubhouse (@keerthivedantam) or Signal at 408-470-0776.
LA Tech ‘Moves’: Adtech Firm OpenX Lures New SVP, Getlabs and DISQO Tap New VPs
Decerry Donato is dot.LA's Editorial Fellow. Prior to that, she was an editorial intern at the company. Decerry received her bachelor's degree in literary journalism from the University of California, Irvine. She continues to write stories to inform the community about issues or events that take place in the L.A. area. On the weekends, she can be found hiking in the Angeles National forest or sifting through racks at your local thrift store.
“Moves,” our roundup of job changes in L.A. tech, is presented by Interchange.LA, dot.LA's recruiting and career platform connecting Southern California's most exciting companies with top tech talent. Create a free Interchange.LA profile here—and if you're looking for ways to supercharge your recruiting efforts, find out more about Interchange.LA's white-glove recruiting service by emailing Sharmineh O’Farrill Lewis (sharmineh@dot.la). Please send job changes and personnel moves to moves@dot.la.
***
Advertising technology company OpenX Technologies appointed Geoff Wolinetz as senior vice president of demand platforms. Wolinetz was most recently senior vice president of growth at Chalice Custom Algorithms.
Remote health care infrastructure provider Getlabs hired Jaime LaFontaine as its vice president of business development. L.A.-based LaFontaine was previously director of business development for Alto Pharmacy.
Customer experience platform DISQO tapped Andrew Duke as its vice president of product, consumer applications. Duke previously served as Oracle’s senior director of strategy and product.
Media company Wheelhouse DNA named Michael Senzer as senior manager of Additive Creative, its newly launched digital talent management division. Senzer was previously vice president of business development at TalentX Entertainment.
Fintech lending platform Camino Financial hired Dana Rainford as vice president of people and talent. Rainford previously served as head of human resources at Westwood Financial.
Kourtney Day returned to entertainment company Jim Henson’s Creature Shop as senior director of business development. Day mostly recently served as business development manager for themed entertainment at Solomon Group.
Decerry Donato is dot.LA's Editorial Fellow. Prior to that, she was an editorial intern at the company. Decerry received her bachelor's degree in literary journalism from the University of California, Irvine. She continues to write stories to inform the community about issues or events that take place in the L.A. area. On the weekends, she can be found hiking in the Angeles National forest or sifting through racks at your local thrift store.
This Week in ‘Raises’: Miracle Miles Lands $100M, Fintech Startup Tapcheck Hauls $20M
Decerry Donato is dot.LA's Editorial Fellow. Prior to that, she was an editorial intern at the company. Decerry received her bachelor's degree in literary journalism from the University of California, Irvine. She continues to write stories to inform the community about issues or events that take place in the L.A. area. On the weekends, she can be found hiking in the Angeles National forest or sifting through racks at your local thrift store.
In this week’s edition of “Raises”: An L.A.-based footwear company closed $100 million to boost its expansion into the global market, while there were Series A raises for local fintech, biotech and space startups.
***
Venture Capital
Miracle Miles Group, an L.A.-based footwear company, raised a $100 million Series A funding round co-led by IDG Capital and Sequoia Capital China.
Deno, a San Diego-based software development startup, raised a $21 million Series A funding round led by Sequoia Capital.
Tapcheck, an L.A.-based financial wellness startup that helps workers access their paycheck before payday, raised a $20 million Series A funding round led by PeakSpan Capital.
Gemelli Biotech, an L.A.- and Raleigh, N.C.-based biotech startup focused on gastrointestinal diseases, raised a $19 million Series A financing round led by Blue Ox Healthcare Partners.
Epsilon3, an L.A.-based space operations software startup, raised a $15 million Series A funding round led by Lux Capital.
Global Premier Fertility, an Irvine-based fertility company, raised an $11 million Series C funding round led by Triangle Capital Corporation.
Vamstar, an L.A.- and London-based medical supply chain platform, raised a $9.5 million Series A funding round co-led by Alpha Intelligence Capital and Dutch Founders Fund.
System 9, an L.A.-based digital asset market-making firm focused on the crypto altcoin market, raised a $5.7 million Series A funding round led by Capital6 Eagle.
Myria, an L.A.-based online marketplace of luxury goods and services, raised a $4.3 million seed round from Y Combinator, Backend Capital, Cathexis Ventures and other angel investors.
Binarly, an L.A.-based firmware cybersecurity company, raised a $3.6 million seed round from WestWave Capital and Acrobator Ventures.
Raises is dot.LA’s weekly feature highlighting venture capital funding news across Southern California’s tech and startup ecosystem. Please send fundraising news to Decerry Donato (decerrydonato@dot.la).
- Vamstar Raises $9.5M For Its Medical Supply Chain Platform - dot.LA ›
- MaC Venture Capital Eyes $200 Million For Its Second Fund - dot.LA ›
- Los Angeles Venture Capital News - dot.LA ›
Decerry Donato is dot.LA's Editorial Fellow. Prior to that, she was an editorial intern at the company. Decerry received her bachelor's degree in literary journalism from the University of California, Irvine. She continues to write stories to inform the community about issues or events that take place in the L.A. area. On the weekends, she can be found hiking in the Angeles National forest or sifting through racks at your local thrift store.